Drugmaker offers $1 rival to $750 pill that sparked outrage
A California, San Diego-based drugmaker Imprimis Pharmaceuticals, is offering a $1 rival to a prescription drug solely supplied by Turing Pharmaceuticals, whose 5, 000 percent price hike last More...
Teva acquires Mexican Rimsa pharmaceutical for $2.3 billion
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is acquiring Rimsa, an independent pharmaceutical company in Mexico with a portfolio of products and patents in Latin America and Europe More...
Mylan battles against Teva takeover: US consumer groups oppose merger
“A takeover of Mylan by Teva is a bad deal for consumers, ” claim. US consumer organizations that have jointly written to the Federal Trade Commission (FTC) demanding that it block the Teva-Mylan More...
Teva launches generic migraine treatment
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has launched generic treatment is for migraine, Axert (almotriptan malate) tablets in 6.25 mg and 12.5 mg dosages, in the US. Teva is the first More...
Mylan to Teva: stop playing games with our company
Mylan reports that Teva Pharmaceutical Industries, which has made an unsolicited offer for the company, violated U.S. anti-trust rules by acquiring a stake, but did not clarify which anti-trust rule More...
Teva Settles Cephalon Case With FTC for $1.2 Billion Over block generic drug competition
Teva Pharmaceutical Industries Ltd. has agreed to pay $1.2 billion in a settlement with the U.S. Federal Trade Commission (FTC), resolving claims that Cephalon Inc. blocked generic drug competition. Teva acquired More...
Teva Buying Auspex for $3.5 Billion in Anticipation of Competition over Copaxone
Read also: CEO Vigodman In Race To Save Teva Through ‘Inorganic Growth’ Just as JBN predicted (along with everybody else in the business) Teva Pharmaceutical Industries Ltd. Decided to buy a major generic More...
Nobel laureate in economics, Joseph Stiglitz: Obama Versus Obamacare
The US Patient Protection and Affordable Care Act, President Barack Obama’s signature 2010 health-care reform, has succeeded in extending insurance coverage to millions of Americans who would not More...
Israeli Teva and Indian Sun Pharmaceuticals to Pay $1.6 billion to Pfizer to Settle Drug Patent Infringement Case
– – / By Alan Gallindoss / Global pharmaceutical company Pfizer announced today that Israeli company Teva Pharmaceuticals Industries and Indian generic drug manufacturer Sun Pharmaceuticals have More...